NewcelX Ltd.
NASDAQ: NCEL0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ronen Twito
- Employees
- 11
- Headquarters
- Zurich, Switzerland
- IPO year
- 2025
- Market cap
- $1.6M
- Website
- https://www.newcelx.com
Loading NCEL…
Loading profile data…Frequently asked questions about NCEL
What does NewcelX Ltd. (NCEL) do?
NewcelX Ltd., a biotechnology firm established in 2008 and based in Zurich, Switzerland, is dedicated to advancing groundbreaking therapeutic solutions. The company's focus lies in developing innovative treatments, utilizing both cell-based and small-molecule approaches, to address challenging neurodegenerative and metabolic diseases.
Where does NCEL trade?
NewcelX Ltd. (NCEL) trades on the NASDAQ Capital Market.
What sector is NCEL in?
NewcelX Ltd. (NCEL) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of NewcelX Ltd.?
Ronen Twito is the chief executive officer of NewcelX Ltd. (NCEL).
Where is NewcelX Ltd. headquartered?
NewcelX Ltd. is headquartered in Switzerland.
Does NCEL pay a dividend?
NewcelX Ltd. (NCEL) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NCEL go public?
NewcelX Ltd. (NCEL) completed its initial public offering in 2025.